2012
DOI: 10.1371/journal.pone.0035157
|View full text |Cite
|
Sign up to set email alerts
|

Protein Signature of Lung Cancer Tissues

Abstract: Lung cancer remains the most common cause of cancer-related mortality. We applied a highly multiplexed proteomic technology (SOMAscan) to compare protein expression signatures of non small-cell lung cancer (NSCLC) tissues with healthy adjacent and distant tissues from surgical resections. In this first report of SOMAscan applied to tissues, we highlight 36 proteins that exhibit the largest expression differences between matched tumor and non-tumor tissues. The concentrations of twenty proteins increased and si… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
68
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 84 publications
(69 citation statements)
references
References 61 publications
1
68
0
Order By: Relevance
“…We are currently investigating the potential of this nascent technology for applications ranging from biomarker discovery and diagnostics (43,44) to histochemistry and imaging (45). With the well-established role of PDGF-BB in proliferative disorders including atherosclerosis, fibrosis, macular degeneration, and cancer (11,46,47), the SOMAmers described here also have clear potential utility as therapeutic agents.…”
Section: Discussionmentioning
confidence: 99%
“…We are currently investigating the potential of this nascent technology for applications ranging from biomarker discovery and diagnostics (43,44) to histochemistry and imaging (45). With the well-established role of PDGF-BB in proliferative disorders including atherosclerosis, fibrosis, macular degeneration, and cancer (11,46,47), the SOMAmers described here also have clear potential utility as therapeutic agents.…”
Section: Discussionmentioning
confidence: 99%
“…This compensates for the additional proofreading steps that would be provided by a second aptamer. Multiplexed assays based on SOMAmers with a mean LOD of 300 fM (m + 3.2 × s) and a dynamic range seven orders of magnitude have been used to identify biomarkers for various medical conditions including lung cancer and chronic kidney disease [63,65].…”
Section: Improving the Specificity Of Affinity Proteomics By Adding Mmentioning
confidence: 99%
“…10,11 More recently, we have been able to adapt our assay protocol to analyze tissue homogenates. 12 Fresh frozen (within 5-10 min of excision) tissue can be homogenized with a mortar and pestle, including a cocktail of protease inhibitors in the homogenization buffer, and diluted to equal protein concentrations, in order to normalize the results for tissue comparison. It was important to verify that our assay buffers did not allow any potential DNase activity from the tissue proteins to degrade the SOMAmers in the assay.…”
mentioning
confidence: 99%
“…12 Analysis of proteins in NSCLC tissue was compared to protein levels in both normal tissue adjacent to the surgical margins and normal tissue distant from the extirpated cancer. Figure 9a shows no significant differences in proteins in adjacent normal tissue compared to distant normal tissue.…”
mentioning
confidence: 99%
See 1 more Smart Citation